News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Thanos Dimopoulos: Honored to present as a LBA the DREAMM 8 at EHA this morning
Photo taken from myeloma-ksa.com
Jun 20, 2024, 07:05

Thanos Dimopoulos: Honored to present as a LBA the DREAMM 8 at EHA this morning

Quoting Thanos Dimopoulos, Rector of the National and Kapodistrian University of Athens, on X:

“Honored to present as a LBA the DREAMM 8 at EHA this morning. Thrilled to have a publication of the study in NEJM.”

Thanos Dimopoulos

Source: Thanos Dimopoulos/X

cancer NEJM OncoDaily Oncology Thanos Dimopoulos
Special Coverage
Blog
Mar 26, 2025, 19:20
Giannis Mountzios: ELCC25 MARIPOSA trial - Overall Survival in 1L EGFR-mutant NSCLC
Insight
Mar 26, 2025, 19:10
Authors Explore the Need Advancing HPV-related Cancer Research and vaccination rates among Arab Americans - ACS Journal Cancer
Blog
Mar 26, 2025, 18:40
The journey living with multiple myeloma can be filled with numerous ups and downs - International Myeloma Foundation
Blog
Mar 26, 2025, 18:32
Juan Gómez Rivas: EAU25 Showcases Science, Innovation, and the Power of Connection in Urology
Blog
Mar 26, 2025, 18:26
Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact - AACR
Blog
Mar 26, 2025, 18:21
Climb of Life Event Has Raised Over £1.5M for Cancer Research Since 2007 - The ICR
Blog
Mar 26, 2025, 18:16
Eric K. Singhi: Breaking news - the Overall Survival results from MARIPOSA are out at ELCC25
Blog
Mar 26, 2025, 18:12
Submit an abstract for the AACR Special Conference
Blog
Mar 26, 2025, 18:03
Molecular tumour board in gastrointestinal cancers
Blog
Mar 26, 2025, 17:58
Enkeleda Duka shares her experience from ESO Clinical Training Centres Fellowship program
Blog
Mar 26, 2025, 17:54
Tbilisi Takes Action to Improve Cancer Care in Georgia - City Cancer Challenge
Blog
Mar 26, 2025, 17:54
Diego A. Díaz García: Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutant advanced NSCLC whose DP on 1L osimertinib